4-1001756-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PP3_ModeratePM2_Supporting
This summary comes from the ClinGen Evidence Repository: The NM_000203.5:c.667G>T variant in IDUA is a missense variant predicted to cause substitution of aspartic acid by tyrosine at amino acid 223 (p.Asp223Tyr). To our knowledge, the results of functional assays have not been reported for this variant and this variant has not been reported in the literature in any individuals with MPS1. The highest population minor allele frequency in gnomAD v4.1.0 is 0.00008029 (6/74728 alleles; no homozygotes) in the African / African American population, which is lower than the ClinGen Lysosomal Diseases VCEP’s threshold for PM2_Supporting (<0.00025), meeting this criterion (PM2_Supporting). The computational predictor REVEL gives a score of 0.87 which is above the threshold of 0.773, evidence that correlates with impact to IDUA function at the moderate level (PP3_Moderate). There is a ClinVar entry for this variant (Variation ID: 1406350). In summary, this variant meets the criteria to be classified as a variant of uncertain significance for MPS I based on the ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert Panel (Specifications Version 1.0.0): PP3_Moderate, PM2_Supporting.(Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on December 6, 2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA91167878/MONDO:0001586/091
Frequency
Consequence
NM_000203.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IDUA | NM_000203.5 | c.667G>T | p.Asp223Tyr | missense_variant | 6/14 | ENST00000514224.2 | NP_000194.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IDUA | ENST00000514224.2 | c.667G>T | p.Asp223Tyr | missense_variant | 6/14 | 2 | NM_000203.5 | ENSP00000425081 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152004Hom.: 0 Cov.: 34
GnomAD4 exome AF: 6.92e-7 AC: 1AN: 1446026Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 719450
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152004Hom.: 0 Cov.: 34 AF XY: 0.0000404 AC XY: 3AN XY: 74238
ClinVar
Submissions by phenotype
Mucopolysaccharidosis type 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 20, 2023 | This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 223 of the IDUA protein (p.Asp223Tyr). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with IDUA-related conditions. ClinVar contains an entry for this variant (Variation ID: 1406350). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt IDUA protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 10, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at